Little Rock, AR, United States of America

Wei Yan

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Bioventures, LLC, The General Hospital Corporation. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Yan. Retrieved from https://idiyas.com/inventor/wei-yan-25csiam6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Wei Yan: Innovator in Cancer Treatment

Introduction

Wei Yan is a prominent inventor based in Little Rock, Arkansas. He has made significant contributions to the field of cancer research and treatment. His innovative work has led to the development of a patent that addresses critical challenges in oncology.

Latest Patents

Wei Yan holds a patent titled "Compositions and Methods for the Treatment and Diagnosis of Cancer." This patent represents a significant advancement in the methodologies used for diagnosing and treating cancer, showcasing his commitment to improving patient outcomes.

Career Highlights

Wei Yan is currently associated with Bioventures, LLC, where he applies his expertise in cancer research. His work at the company has been instrumental in advancing therapeutic strategies that target cancer more effectively.

Collaborations

Wei Yan collaborates with notable colleagues, including Hong-yu Li and Li Lan. These partnerships enhance the research efforts and contribute to the innovative solutions being developed in the field of cancer treatment.

Conclusion

Wei Yan's contributions to cancer research through his patent and work at Bioventures, LLC highlight his role as a key innovator in the medical field. His dedication to improving cancer treatment continues to inspire advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…